Drug Interactions between darifenacin and Vowst
This report displays the potential drug interactions for the following 2 drugs:
- darifenacin
- Vowst (fecal microbiota spores, live)
Interactions between your drugs
No interactions were found between darifenacin and Vowst. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
darifenacin
A total of 426 drugs are known to interact with darifenacin.
- Darifenacin is in the drug class urinary antispasmodics.
- Darifenacin is used to treat the following conditions:
Vowst
A total of 132 drugs are known to interact with Vowst.
- Vowst is in the drug class miscellaneous uncategorized agents.
- Vowst is used to treat Prevention of Recurrent Clostridioides difficile Infection.
Drug and food interactions
fecal microbiota spores, live food
Applies to: Vowst (fecal microbiota spores, live)
ADJUST DOSING INTERVAL: There are no data regarding the effects of concurrent administration of oral fecal microbiota spores with food.
MANAGEMENT: The manufacturer of the oral formulation of fecal microbiota recommends that patients should have no food or drink except for a small amount of water for at least 8 hours prior to the first dose of fecal microbiota spores. The second and third doses of fecal microbiota spores should be taken on an empty stomach prior to the first meal of the day.
References (1)
- (2023) "Product Information. Vowst (fecal microbiota spores, live)." Aimmune Therapeutics
darifenacin food
Applies to: darifenacin
The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin. The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits. The clinical significance is unknown.
References (1)
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.